Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Genomic Health, Inc. (NASDAQ: GHDX).

Full DD Report for GHDX

You must become a subscriber to view this report.


Recent News from (NASDAQ: GHDX)

Multiple Oncotype DX Study Presentations at the 2018 San Antonio Breast Cancer Symposium Reinforce Real-world Value of the Oncotype DX Breast Recurrence Score® Test in Patients Regardless of Age or Race
REDWOOD CITY, Calif. , Dec. 10, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple Oncotype DX Breast Recurrence Score ® (RS) presentations at the 2018 San Antonio Breast Cancer Symposium ® (SABCS), reinforcing the value of the Oncot...
Source: PR Newswire
Date: December, 10 2018 08:00
Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX® Genomic Prostate Score® Test
REDWOOD CITY, Calif. and MECHELEN, Belgium , Dec. 3, 2018 /PRNewswire/ --  Genomic Health , Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests and Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today ...
Source: PR Newswire
Date: December, 03 2018 16:51
Undervalued Stocks With Rising Earnings Expectations
Simplicity is the ultimate sophistication. The more simple and straightforward the rationale for buying a stock, the better the chances of success. At the end of the day, investing is all about answering two main questions: what to buy and when to buy it. This article is introducing a quanti...
Source: SeekingAlpha
Date: December, 03 2018 11:38
Genomic Health Q3 beat and guidance raise propel shares, up 24%
Genomic Health ( GHDX +23.5% ) is up on modestly higher volume after releasing better-than-expected results after the close yesterday. Highlights: More news on: Genomic Health, Inc., Read more ...
Source: SeekingAlpha
Date: November, 07 2018 10:48
Genomic Health, Inc. (GHDX) CEO Kim Popovits on Q3 2018 Results - Earnings Call Transcript
Genomic Health, Inc. (GHDX) Q3 2018 Results Conference Call November 06, 2018 04:30 PM ET Executives Emily Faucette - Vice President of Corporate Communications and Investor Relations Kim Popovits - Chairman of the Board, Chief Executive Officer and President Brad Cole - Chief Fi...
Source: SeekingAlpha
Date: November, 06 2018 19:25
Genomic Health beats by $0.27, beats on revenue
Genomic Health (NASDAQ: GHDX ): Q3 GAAP EPS of $0.32 beats by $0.27 . More news on: Genomic Health, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 16:31
Genomic Health Announces Record Revenue and Profit in Third Quarter 2018 Financial Results; Raises Full Year Guidance
REDWOOD CITY, Calif. , Nov. 6, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended September 30, 2018 . "We continue to deliver record results in 2018, including 23 percent revenue growth and $...
Source: PR Newswire
Date: November, 06 2018 16:05
Notable earnings after Tuesday's close
ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...
Source: SeekingAlpha
Date: November, 05 2018 17:35
Genomic Health to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 6, 2018
REDWOOD CITY, Calif. , Oct. 30, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ:  GHDX) today announced that the company will host a conference call and webcast on Tuesday, November 6 at 4:30 p.m. Eastern Time to discuss its third quarter 2018 financial results. The call and we...
Source: PR Newswire
Date: October, 30 2018 08:00
Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castrate Resistant Prostate Cancer Effective December 10
SAN DIEGO and REDWOOD CITY, Calif. , Oct. 29, 2018 /PRNewswire/ --  Epic Sciences, Inc. (Epic) and Genomic Health, Inc. (Nasdaq: GHDX) announced today that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive fin...
Source: PR Newswire
Date: October, 29 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0861.4262.4563.5760.90245,017
2018-05-1738.0138.2438.3837.76152,103
2018-02-2632.7832.1333.0330.92353,616
2018-02-2331.5632.7833.0831.56251,600
2018-02-2232.8931.4033.2631.04306,263

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1819,54547,96840.7459Short
2018-12-1740,804125,14132.6064Cover
2018-12-1448,17479,62960.4981Short
2018-12-1326,67955,92547.7050Short
2018-12-1210,78036,82429.2744Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GHDX.


About Genomic Health, Inc. (NASDAQ: GHDX)

Logo for Genomic Health, Inc. (NASDAQ: GHDX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $1,341,267,240 - 05/16/2018
  • Issue and Outstanding: 35,380,653 - 04/30/2018

 


Recent Filings from (NASDAQ: GHDX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 14 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: March, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: March, 08 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: February, 20 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 25 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: December, 14 2017

 

 


Daily Technical Chart for (NASDAQ: GHDX)

Daily Technical Chart for (NASDAQ: GHDX)


Stay tuned for daily updates and more on (NASDAQ: GHDX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: GHDX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GHDX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GHDX and does not buy, sell, or trade any shares of GHDX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/